IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q2 FY24 results · Jul–Sep 2023
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹545.30 crore (up 0.7% from Q2 FY23) and net profit of ₹37.87 crore (up 138.0% from Q2 FY23) for Q2 FY24 (Jul–Sep 2023), on a consolidated basis.
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 545.30 | 541.41 | +0.7% | 563.18 | −3.2% |
| Other income | 7.11 | 5.07 | +40.2% | 7.06 | +0.7% |
| Total income | 552.41 | 546.48 | +1.1% | 570.24 | −3.1% |
| Profit before tax | 51.18 | 22.14 | +131.2% | 61.18 | −16.3% |
| Net profit for the period | 37.87 | 15.91 | +138.0% | 45.86 | −17.4% |
| EPS, basic (₹) | 6.45 | 2.71 | +138.0% | 7.81 | −17.4% |
| Net margin (%) | 6.9 | 2.9 | 8.1 |
| Item | Q2 FY24 | Q2 FY23 | YoY | Q1 FY24 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 545.30 | 541.41 | +0.7% | 563.18 | −3.2% |
| Other income | 7.11 | 5.06 | +40.5% | 7.06 | +0.7% |
| Total income | 552.41 | 546.47 | +1.1% | 570.24 | −3.1% |
| Profit before tax | 51.10 | 21.90 | +133.3% | 61.53 | −17.0% |
| Net profit for the period | 37.79 | 15.67 | +141.2% | 46.21 | −18.2% |
| EPS, basic (₹) | 6.44 | 2.67 | +141.2% | 7.87 | −18.2% |
| Net margin (%) | 6.9 | 2.9 | 8.2 |
Consolidated
- Filed with BSE
- 10 Nov 2023, 18:49 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Audited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 10 Nov 2023, 18:49 IST
- Board meeting
- 08 Nov 2023
- Period
- 01 Jul 2023 to 30 Sep 2023
- Review status
- Audited
- Source
- XBRL filing on BSE